KR101398392B1 - cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle - Google Patents

cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle Download PDF

Info

Publication number
KR101398392B1
KR101398392B1 KR1020080022256A KR20080022256A KR101398392B1 KR 101398392 B1 KR101398392 B1 KR 101398392B1 KR 1020080022256 A KR1020080022256 A KR 1020080022256A KR 20080022256 A KR20080022256 A KR 20080022256A KR 101398392 B1 KR101398392 B1 KR 101398392B1
Authority
KR
South Korea
Prior art keywords
skin wrinkles
effect
cosmetic composition
improving skin
extract
Prior art date
Application number
KR1020080022256A
Other languages
Korean (ko)
Other versions
KR20090097232A (en
Inventor
유병삼
임자훈
김재우
문지영
Original Assignee
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스 주식회사 filed Critical 코스맥스 주식회사
Priority to KR1020080022256A priority Critical patent/KR101398392B1/en
Publication of KR20090097232A publication Critical patent/KR20090097232A/en
Application granted granted Critical
Publication of KR101398392B1 publication Critical patent/KR101398392B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Abstract

본 발명은 주름개선 효과를 갖는 가막살나무(Viburnum dilatatum Thunb.) 잎, 가지 혼합 추출물에 관한 것으로, 가막살나무(Viburnum dilatatum Thunb.) 잎, 가지 혼합 추출물이 MMP-1과 elastase을 저해하는 우수한 효과가 있음을 밝혀 피부주름개선용 화장료조성물에 사용하고자 하는 것이다.The present invention relates to a method for producing wrinkle- dilatatum Thunb.) Leaf and Branch Mixture Extracts, Viburnum dilatatum Thunb.) leaves and leaves have an excellent effect of inhibiting MMP-1 and elastase, and are intended to be used in cosmetic compositions for improving skin wrinkles.

가막살나무, 화장료, 피부주름, elastase, MMP-1 Giblets, cosmetics, skin wrinkles, elastase, MMP-1

Description

가막살나무 추출물을 포함하는 피부주름 개선용 화장료 조성물 {cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle}[0001] The present invention relates to a cosmetic composition containing an extract of Cinnamomum cassia var. Viburnum dilatatum Thunb used for antiwrinkle,

본 발명은 주름 개선 효과를 갖는 가막살나무 잎, 가지 혼합 추출물에 관한 것으로, 가막살나무 잎, 가지 혼합 추출물이 MMP-1과 elastase을 저해하며, 콜라겐 합성을 촉진하는 우수한 효과가 있음을 밝혀 피부주름 개선용 화장료조성물에 사용하고자 하는 것이다.The present invention relates to a mixed extract of cinnamon leaf and eggplant having a wrinkle-reducing effect, and it has been found that an extract of cinnamon leaf and gangliosate inhibits MMP-1 and elastase and has an excellent effect of promoting collagen synthesis. Which is intended to be used in a cosmetic composition for use in cosmetics.

사람의 피부는 25세를 전후해서 노화가 촉진되는데 자연노화와 외적노화로 구분되며, 자연노화는 유전적 요소에 주로 기인하므로 조절하기 어렵다. 외적노화는 오염물과 먼지, 공해, 자외선 등 외부 요인에 의해 발생하므로 인위적 조절이 가능하다. 이 중 특히 피부가 자외선에 노출 되었을 때 섬유아세포에서 활성산소종이 생성되어 콜라게네이즈(collagenase, 이하 "MMP-1"라 한다)의 발현이 유도된다.(Yoshiharu Kawaguchi et al. ,1996)Skin aging is promoted around the age of 25, and is divided into natural aging and external aging. Natural aging is difficult to control because it is mainly caused by genetic factors. External aging is caused by external factors such as pollutants, dust, pollution, and ultraviolet rays, so that man-made control is possible. In particular, when skin is exposed to ultraviolet rays, reactive oxygen species are generated in fibroblasts and induce the expression of collagenase (hereinafter referred to as "MMP-1") (Yoshiharu Kawaguchi et al . , 1996)

MMP-1은 세포의 기질인 콜라겐을 분해하는 효소로서 기질 금속단백질분해효소(matrixmetalloprpteinase, 이하 'MMP'라 칭함)의 한 종류이다.MMP-1 is a kind of matrix metalloproteinase (hereinafter referred to as 'MMP') as an enzyme that degrades collagen, which is a substrate of cells.

MMP-1은 콜라겐 타입 I을 분해한다. 따라서 MMP-1의 발현이 유도되면 콜라겐의 합성이 감소하여 피부에 주름이 발생하게 된다.(Laure Rittie et al., 2002)MMP-1 degrades collagen type I. Therefore, when MMP-1 expression is induced, collagen synthesis is reduced and wrinkles occur on the skin. (Laure Rittie et al ., 2002)

또한, 엘라스틴(elastin)는 콜라겐과 같이 피부 탄력에 관여하고 있는 주름생성에 중요한 섬유조직이다. 엘라스틴 섬유의 결핍과 응집, 엘라스타아제의 활성도의 현격한 증가는 피부주름 생성 요인 중 하나이다. 엘라스틴을 분해할 수 있는 유일한 효소인 엘라스타아제를 저해하는 것은 피부 주름을 근본적으로 줄여 줄 수 있다고 알려져 있다.(Lee et al,. 1999)In addition, elastin is a fiber structure important for the generation of wrinkles, which is involved in skin elasticity like collagen. Deficiency and aggregation of elastin fibers, and a marked increase in the activity of elastase is one of the causes of skin wrinkles. It is known that inhibiting elastase, the only enzyme capable of degrading elastin, can fundamentally reduce skin wrinkles (Lee meat al . 1999)

자외선에 의한 광화학반응으로 수퍼옥사이드 라디칼, 하이드록실 라디칼, 과산화수소, 일중합산소와 같은 반응성이 매우 큰 활성 산소를 생성하여 세포구성 성분들인 지질, 단백질, 당, DNA 등에 대하여 비선택적, 비가역적 파괴작용을 함으로써 피부노화를 일으킨다.(Halliwell, 1991)Ultraviolet light-induced photochemical reactions produce highly reactive reactive oxygen species such as superoxide radicals, hydroxyl radicals, hydrogen peroxide, and mono-polymerized oxygen, which causes non-selective, irreversible destruction of cellular components such as lipids, proteins, , Which causes skin aging (Halliwell, 1991).

항산화물질은 동·식물체 및 미생물에 이르기까지 자연계에 널리 분포하는 물질로서 산화적피해를 야기하는 프리라디칼을 억제하여 피부노화를 예방하고 억제할 수 있다.Antioxidants are widely distributed in the natural world, ranging from plants, plants and microorganisms, and can prevent and inhibit skin aging by inhibiting free radicals that cause oxidative damage.

지금까지 연구 보고된 주름완화 및 피부노화 예방 물질로는 레티놀, 아데노신, AHA 등이 개발되어 있으나 안전성이 떨어지며 피부자극을 유발하고 뚜렷한 가시적인 효과가 미흡하다는 문제점을 안고 있다. 따라서 앞선 문제점들을 보완할 수 있는 주름개선 및 피부노화예방 소재 연구가 필요한 상황이다.Although retinol, adenosine, and AHA have been developed as anti-wrinkle agents and anti-aging agents reported in the previous researches, they are less safe, cause skin irritation, and have poor visibility. Therefore, it is necessary to study wrinkle improvement and skin aging prevention materials that can solve the above problems.

가막살나무는 인동과 식물로서 산 중턱 이하의 숲속에 나는 낙엽관목으로 3m가량 자라며, 잎은 대생, 둥근 모양이며 길이는 6~12cm 정도 자란다. 가장자리에 톱니가 있고, 양면에 털이 있으며, 뒷면에 선점이 있고, 양끝이 좁고, 턱잎은 없다. 꽃은 흰색이며, 열매는 붉은색을 띈다. 우리나라 강원도이남 특히 제주도에 자생하며, 관상용으로 많이 쓰이고 있다. 가막살나무 줄기나 잎을 협미라고 불리으며 봄과 여름에 채취하여 약용한다. 열매와 어린순은 식용으로 사용하기도 하며, 가막살나무 열매에는 항산화효과가 있다고 알려지고 있다(Kunihisa Iwai, et al,. 2004). 그러나, 가막살나무와 관련된 생리활성 연구는 진행되어 있지 않다.It is a deciduous shrub that grows in the forest below the middle of the mountain and grows about 3m in length. Its leaves are round, round and 6 ~ 12cm long. There are serrations on the edge, hairs on both sides, there is a prefix on the back, both ends are narrow, and there is no stipple. The flower is white and the fruit is red. It is native to Gangwon-do in Korea and especially in Jeju-do, and is widely used for ornamental purposes. It is called spring coat and leaves, and it is collected in spring and summer and used medicinally. Fruit and lysoon are also used for edible purposes, and it is known that fenugreek fruit has antioxidant effects (Kunihisa Iwai, et al . 2004). However, studies on the physiological activity related to giblets have not been conducted yet.

본원 발명은 천연유래추출물을 함유하는 피부주름개선용 화장료조성물을 제공하고자 하는 것으로, 가막살나무 추출물이 피부주름개선에 효과가 있음을 밝혀 이를 함유하는 피부주름개선용 화장료조성물을 제공하는 것을 목적으로 한다.The present invention aims to provide a cosmetic composition for improving skin wrinkles containing a naturally derived extract, and it is an object of the present invention to provide a cosmetic composition for improving skin wrinkles containing the extract of Cinnamomum cassia bark extract to improve skin wrinkles .

본 발명은 주름 개선 효과를 갖는 가막살나무(Viburnum dilatatum Thunb.) 추출물에 관한 것으로, 구체적으로는 가막살나무 잎, 가지 혼합 추출물이 elastase와 MMP-1을 저해하며, 콜라겐합성을 촉진하는 효과가 있음을 밝혀 가막살나무 잎, 가지 혼합 추출물을 함유하는 피부주름 개선용 화장료조성물을 제공한다.The present invention relates to a method for producing wrinkle- dilatatum Thunb.) extracts. Specifically, it has been found that the extracts of gabbrook leaves and leaves have an effect of inhibiting elastase and MMP-1 and promoting collagen synthesis. A cosmetic composition for improving wrinkles is provided.

본 발명의 가막살나무 추출물을 제조하기 위한 추출용매로는 메탄올, 에탄올 등이 있으며, 에탄올이 가장 바람직하다.The extraction solvent for preparing the cinnamon extract of the present invention includes methanol, ethanol and the like, and ethanol is most preferable.

본 발명의 피부주름 개선용 화장료조성물은 가막살나무 추출물(잎, 가지 혼합추출물)을 조성물 전체 중량의 0.005 내지 1 중량% 함유한다.The cosmetic composition for improving skin wrinkles of the present invention contains from 0.005 to 1% by weight of the total amount of the cinnamon bark extract (leaf, branch mixture).

0.005 중량% 이하 함유시는 본 발명의 피부주름개선효과를 기대하기 어렵고, 1 중량% 이상 함유시는 제제화에 어려움이 있을 수 있다.When the content is 0.005% by weight or less, the effect of improving the skin wrinkles of the present invention is hardly expected, and when the content is 1% by weight or more, it may be difficult to formulate the composition.

본 발명의 피부주름 개선용 화장료조성물은 일반화장수, 크림제, 맛사지팩 등으로 제공될 수 있으며, 통상적인 제제화 방법에 따라 제형화할 수 있다.The cosmetic composition for improving skin wrinkles of the present invention may be provided as general lotion, cream, massage pack, etc., and may be formulated according to a conventional formulation method.

본 발명의 가막살나무 잎, 가지 혼합 추출물은 우수한 항산화활성이 있고, elastase와 MMP-1을 저해함과 동시에 콜라겐합성을 촉진하는 효과가 있어 피부주름개선용 화장료조성물에 유용하게 사용할 수 있다.The mixed extract of V. falcatum and leaves of the present invention has an excellent antioxidative activity, and has an effect of inhibiting elastase and MMP-1 and promoting collagen synthesis, so that it can be usefully used in a cosmetic composition for improving skin wrinkles.

실시예 1: 가막살나무 잎, 가지 혼합 추출물(이하 'VD-LBE'라 칭함) 제조Example 1: Production of a mixed extract of cinnamon leaf and garlic (hereinafter referred to as "VD-LBE")

가막살나무 잎과 가지를 채취하여 시료를 정제수로 세척하고 건조하여 분쇄하였다. 건조 분쇄된 가막살나무 잎 50g과 가지 50g를 혼합한 시료 100g을 80중량% 에탄올 2L로 상온에서 초음파를 이용하여 4시간 동안 2회 반복 추출한 다음 어드반택 NO.4(제조판매원: Toyo Roshi Kaisha Ltd.) 여과포로 여과 하였다. 여액을 감압회전농축기를 이용하여 건조중량 19.59g을 얻었다.The leaves and branches of V. chinensis were collected and the samples were washed with purified water, dried and pulverized. 100 g of a sample obtained by mixing 50 g of the dried pulp leaves with 50 g of the branch was repeatedly extracted with 2 L of 80% by weight ethanol at room temperature for 4 hours twice by using ultrasonic waves, followed by addition of Advanan NO.4 (manufactured by Toyo Roshi Kaisha Ltd.). ) Filter cake. The filtrate was dried to a weight of 19.59 g using a rotary evaporator under reduced pressure.

실시예 2: VD-LBE의 용매 분획물 제조Example 2: Preparation of solvent fractions of VD-LBE

실시예 1에서 얻은 가막살나무 잎, 가지 혼합 추출물 10g을 충분한 용량의 증류수에 용해한 후, 이것과 동일 부피의 헥산, 메틸렌클로라이드, 에틸아세테이트, 부탄올을 순차적으로 가한 후 용매분획을 실시하여 헥산 분획물 0.930g, 메틸렌클로라이드 분획물 1.621g, 에틸아세테이트 분획물 1.024g, 부탄올 분획물 1.981g을 얻어냈다.10 g of the mixed extract of cinnamomum flavia and leaves obtained in Example 1 was dissolved in a sufficient volume of distilled water and then hexane, methylene chloride, ethyl acetate and butanol were added in the same volume as that of the same, followed by solvent fractionation to obtain 0.930 g 1.621 g of methylene chloride fraction, 1.024 g of ethyl acetate fraction and 1.981 g of butanol fraction.

실험예 1: DPPH라티칼 소거활성능력 측정실험에 의한 항산화 효능 평가Experimental Example 1: Evaluation of antioxidant activity by DPPH radical scavenging activity assay

본 실험예에서는 수득한 시료들의 DPPH 라디칼 소거활성을 측정하여 항산화력을 확인하였다. 추출물들의 항산화능력을 기존의 항산화제인 vitamin C와 비교 측정하였다. DPPH(1,1-디페닐-2-피크릴히드라진) 2.96㎎을 에탄올 50㎖에 녹여 0.2mM DPPH 용액을 만들었다. 항산화능을 측정하고자 하는 시료를 에탄올에 녹여 희석한 96공 평판 플레이드에 150㎕씩 분주한 다음 DPPH 용액 150㎕를 시료액과 30분간 반응시키고 microplate reader를 사용하여 517nm에서 흡광도를 측정하였다. 시료 대신 에탄올을 넣은 반응액을 대조군으로 하여 라디칼 소거능력을 측정하였다. 이때 사용된 계산식은 아래와 같다.In this experimental example, DPPH radical scavenging activity of the obtained samples was measured to confirm antioxidant activity. The antioxidant capacity of the extracts was compared with vitamin C, a conventional antioxidant. 2.96 mg of DPPH (1,1-diphenyl-2-picrylhydrazine) was dissolved in 50 mL of ethanol to prepare a 0.2 mM DPPH solution. The samples to be tested for antioxidant activity were dissolved in ethanol and diluted to a volume of 150 μl in a 96-well plate plate. 150 μl of the DPPH solution was reacted with the sample solution for 30 minutes and absorbance was measured at 517 nm using a microplate reader. The reaction solution containing ethanol instead of the sample was used as a control to measure the radical scavenging ability. The formula used at this time is as follows.

Scavenge(%) = {1-(A-B)/C}×100Scavenge (%) = {1- (A-B) / C} 100

A : 시료액과 DPPH 용액을 반응시킨 실험군의 흡광도A: Absorbance of the experimental group reacted with the sample solution and the DPPH solution

B : 시료액 자체 흡광도B: Sample liquid self-absorbance

C : 에탄올과 DPPH 용액을 반응시킨 실험군의 흡광도C: Absorbance of the experimental group reacted with ethanol and DPPH solution

항산화활성 효과 실험  Experiment of antioxidant activity
시료

sample
DPPH Scavenge(%)DPPH Scavenge (%) SC50
(㎍/㎖)
SC 50
(占 퐂 / ml)
처리농도(㎍/㎖)Treatment concentration ([mu] g / ml) 1One 55 1010 3030 5050 100100 VD-LBEVD-LBE 11.1011.10 22.1122.11 35.2435.24 79.7779.77 92.6292.62 94.0894.08 17.0317.03 VD-LBE
헥산 분획물
VD-LBE
Hexane fraction
9.479.47 11.0911.09 12.4112.41 17.9717.97 23.6723.67 38.5538.55 >100> 100
VD-LBE
메틸렌클로라이드 분획물
VD-LBE
Methylene chloride fraction
8.598.59 11.1311.13 16.3216.32 28.7928.79 41.6841.68 62.6362.63 61.9361.93
VD-LBE
에틸아세테이트 분획물
VD-LBE
Ethyl acetate fraction
15.4115.41 28.2028.20 46.7246.72 87.6387.63 93.9393.93 94.8994.89 13.9713.97
VD-LBE
부탄올 분획물
VD-LBE
Butanol fraction
12.3712.37 27.7027.70 49.0849.08 92.0692.06 93.4893.48 94.4994.49 10.3010.30
1One 55 1010 -- -- Vitamin CVitamin C 15.0715.07 58.4858.48 94.8294.82 -- 4.644.64

표 1에서 나타난 바와 같이 가막살나무 잎, 가지 혼합 에탄올 추출물의 자유라디칼 소거 효과는 농도 의존적으로 증가함을 확인하였으며, 에탄올 추출물, 에틸아세테이트 분획물, 부탄올 분획물 순으로 항산화 활성 효과가 증가함을 알 수 있었다. 따라서 부탄올 분획물에서 항산화 활성 유효지표물질이 존재할 것으로 예상된다As shown in Table 1, the free radical scavenging effect of the ethanol extract of V. fructus was increased in a concentration-dependent manner, and ethanol extract, ethyl acetate fraction and butanol fraction showed an increase in antioxidant activity . Therefore, antioxidant activity indicators are expected to exist in the butanol fraction

실험예 2: 엘라스타아제(elastase)의 활성저해측정 실험Experimental Example 2: Measurement of activity inhibition of elastase

본 실험예에서 수득한 시료들의 엘라스타아제 활성 저해 효과를 관찰하기 위해 수행 하였다. 먼저 트리스 완충액(0.2M Tris buffer, pH8.00) 140㎕와 농도별 시료 20㎕, 그리고 5mM N-Succinyl-Ala-Ala-p-nitroanilide(Sigma, S4760) 20㎕씩 기질용액을 첨가한 다음, 10㎕/㎖의 elastase(Sigma, E7885) 20㎕와 잘 혼합하여 상온(25℃)에서 15분간 반응 시킨 후 410nm에서 생성된 p-nitroaniline의 양을 측정하였다. 양성 대조군으로서는 빈랑자 추출물(대한민국 특허 출원 : 1997-78817)을 사용하였다. 각 시료의 엘라스타아제 활성 저해효과는 효소활성을 50% 소거하는 농도인 IC50으로 표시하였다. 이때 음성대조군으로는 시료를 처리하지 않은 실험액의 흡광도 값으로 하였다. In order to observe the elastase activity inhibitory effect of the samples obtained in this Experimental Example, First, 140 μl of Tris buffer (0.2 M Tris buffer, pH 8.00), 20 μl of each concentration sample, and 20 μl of 5 mM N-Succinyl-Ala-Ala-p-nitroanilide (Sigma, S4760) After mixing well with 20 μl of 10 μl / ml of elastase (Sigma, E7885) and reacting at room temperature (25 ° C) for 15 minutes, the amount of p-nitroaniline produced at 410 nm was measured. As a positive control, bingo extract (Korea patent application: 1997-78817) was used. The inhibitory effect of each sample on the elastase activity was expressed as IC 50, which is a concentration for eliminating the enzyme activity by 50%. As a negative control, the absorbance of the untreated sample was used.

elastase 저해효과  elastase inhibitory effect
시료

sample
elastase inhibition(%)elastase inhibition (%) IC50
(㎍/㎖)
IC 50
(占 퐂 / ml)
처리농도(㎍/㎖)Treatment concentration ([mu] g / ml) 1010 5050 100100 200200 VD-LBEVD-LBE 4.304.30 39.9039.90 72.2072.20 81.3281.32 63.8063.80 VD-LBE
헥산 분획물
VD-LBE
Hexane fraction
5.515.51 16.9716.97 20.4920.49 36.5436.54 >200> 200
VD-LBE
메틸렌클로라이드 분획물
VD-LBE
Methylene chloride fraction
17.8317.83 40.9440.94 60.2960.29 67.4567.45 75.0375.03
VD-LBE
에틸아세테이트 분획물
VD-LBE
Ethyl acetate fraction
8.398.39 27.7727.77 42.7342.73 59.8659.86 132.7132.7
VD-LBE
부탄올 분획물
VD-LBE
Butanol fraction
20.5520.55 41.5941.59 55.5155.51 72.7172.71 74.5374.53
빈랑자추출물Bingo extract 4.734.73 16.4716.47 57.1557.15 -- 4343

표 2에서 나타난 바와 같이 에탄올 추출물이 가장 우수한 엘라스테아제 저해 효과를 나타내었으며, 정제 분획과정으로 엘라스테아제 저해효과가 향상되지 않는 것을 확인하였다.As shown in Table 2, the ethanol extract showed the best inhibitory effect on the elastase, and it was confirmed that the inhibition effect of the elastase was not improved by the purified fractionation process.

실험예 3: 콜라게나제(MMP-1)의 활성 저해 측정 실험Experimental Example 3: Measurement of inhibitory activity of collagenase (MMP-1)

본 실험예에서는 수득한 시료들의 콜라게나제(MMP-1)의 활성 저해효과를 관찰하기 위해 수행 하였으며, 정제된 콜라게나제와 플루오레세인에 접합된 콜라겐의 이용을 기초로 한다. 먼저, 반응 완층액(0.05M Tri-HCl, 0.15M NaCl, 5mM CaCl2, 0.02mM NaN3, pH7.3) 100㎕에 0.25㎎/㎖의 DQTM콜라겐 용해액(Molecular probes, USA) 20㎕와 농도별 시료를 40㎕씩 첨가한 다음, 5Unit의 콜라게나제(GIBCO, USA) 40㎕와 잘 혼합하여 암소, 상온에서 20분간 반응하였다. 그 후 형광분광광도계를 이용하여 흡수파장 495nm, 방출파장 515nm에서 형광값을 측정하였다. 양성 대조군으로서는 실시예의 물질 대신 녹차추출물(S. Pillai, C. Oresajo, and J. Hayward, Int. J. Cosmet. Sci., 27, 17-34, 2005)을 사용하였다. 참고로, 녹차 추출물에 대한 콜라게네이즈 효소생성억제 작용은 대한민국 특허 특1999-0056976에 개시되어 있으며, 녹차 추출물이 자외선에 의한 콜라게네이즈 생성을 억제하며 홍반 및 과산화지질의 억제 정도가 탁월하여 화장료조성물로 활용이 가능하다고 밝힌바 있다.In this Experimental Example, the effect of the collagenase (MMP-1) on the activity of the obtained samples was examined, and the use of the collagenase conjugated with purified collagenase and fluorescein was performed. First, 20 μl of 0.25 mg / ml DQ TM collagen solution (Molecular Probes, USA) was added to 100 μl of the reaction complete layer solution (0.05 M Tri-HCl, 0.15 M NaCl, 5 mM CaCl 2 , 0.02 mM NaN 3 , pH 7.3) And 40 μl of each sample were added to each well and mixed well with 40 μl of 5 units of collagenase (GIBCO, USA). The mixture was reacted in a dark place at room temperature for 20 minutes. Thereafter, fluorescence values were measured at an absorption wavelength of 495 nm and an emission wavelength of 515 nm using a fluorescence spectrophotometer. Green tea extract (S. Pillai, C. Oresajo, and J. Hayward, Int. J. Cosmet. Sci., 27, 17-34, 2005) was used as a positive control. For reference, the inhibitory action of collagenase production on green tea extract is disclosed in Korean Patent Publication No. 1999-0056976. The green tea extract inhibits collagenase production by ultraviolet rays, and the degree of suppression of erythema and lipid peroxidation is excellent, It is possible to use it as a composition.

각 시료의 콜라게나제의 활성 저해효과는 효소활성을 50% 소거하는 농도인 IC50으로 표시하였다. 이때 음성 대조군으로는 시료를 처리하지 않은 실험액의 형광값으로 하였다. The inhibitory effect of collagenase on the activity of each sample was expressed by IC 50, which is a concentration for eliminating the enzyme activity by 50%. As a negative control, the fluorescence value of the untreated test solution was used.

MMP-1 저해효과  MMP-1 inhibitory effect 시료sample MMP-1 Inhibition(%)MMP-1 Inhibition (%) IC50
(㎍/㎖)
IC 50
(占 퐂 / ml)
처리농도(㎍/㎖)Treatment concentration ([mu] g / ml) 1010 5050 200200 VD-LBEVD-LBE 23.1223.12 81.4181.41 99.3499.34 28.5028.50 VD-LBE
헥산 분획물
VD-LBE
Hexane fraction
14.2814.28 25.0425.04 46.6146.61 >200> 200
VD-LBE
메틸렌클로라이드 분획물
VD-LBE
Methylene chloride fraction
16.6516.65 39.4639.46 86.5886.58 83.5483.54
VD-LBE
에틸아세테이트 분획물
VD-LBE
Ethyl acetate fraction
31.2931.29 69.9769.97 99.0899.08 22.1422.14
VD-LBE
부탄올 분획물
VD-LBE
Butanol fraction
46.1946.19 97.4597.45 99.3199.31 11.2711.27
녹차추출물Green tea extract 25.4125.41 35.9035.90 70.9070.90 111.64111.64

표 3에서 나타난 바와 같이 VD-LBE, 메틸렌클로라이드 분획물, 에틸아세테이트 분획물, 부탄올 분획물에서 기존의 MMP-1 저해제로 잘 알려진 녹차추출물보다 더 높은 MMP-1 저해효과를 나타냄을 확인하였다. 특히 부탄올 분획물은 에탄올 추출물보다 2배 이상 우수한 저해 활성을 나타내었다. 따라서 부탄올 분획물에서 MMP-1 활성을 저해하는 유효지표물질이 존재할 것으로 예상된다.As shown in Table 3, it was confirmed that VD-LBE, methylene chloride fraction, ethylacetate fraction, and butanol fraction exhibited higher MMP-1 inhibitory effect than green tea extract, which is well-known as a conventional MMP-1 inhibitor. Particularly, the butanol fraction showed more than two times more inhibitory activity than the ethanol extract. Therefore, it is expected that there will be an effective indicator substance which inhibits MMP-1 activity in the butanol fraction.

실험예 4: 콜라겐 합성 촉진 효과 측정 실험EXPERIMENTAL EXAMPLE 4: Experiment for Measuring Effect of Promoting Collagen Synthesis

본 실험예에서는 수득한 시료들의 콜라겐의 합성 촉진효과를 측정하기 위해서 상업적으로 구입한 인간의 섬유아세포에 시료를 처리하여 실험을 실시하였다.In this Experimental Example, in order to measure the promoting effect of the collagen synthesis of the obtained samples, a commercially available human fibroblast was treated with a sample.

96공 평판 배양기(96-well plate)에 5% 우태아혈청이 함유된 IMD(Iscove's Modified Dulbesco's Media) 배지와 함께 ATCC(Americal Type Culture Collection)에서 구입한 인간의 정상섬유아세포(CCD-985sk)를 5000 세포/well 농도로 분주하고 24시간 동안 37℃, 10% CO2 조건에서 배양하였다. 24시간 후 시료를 우태아혈청이 포함되지 않은 IMDM 배지에 농도별로 희석하여 2일 동안 처리하고 세포배양액을 채취하였다. 채취한 세포배양액을 콜라겐 단백질 측정기구(Procollagen Type I-C-peptide EIA Kit(MK101), Takara. Kyoto, Japan)를 이용하여 프로콜라겐(Procollagen) 타입 IC-펩타이드(Type IC-peptide : PICP) 합성양을 측정하였다.Human normal fibroblasts (CCD-985sk) purchased from the American Type Culture Collection (ATCC) with IMD (Iscove's Modified Dulbesco's Media) medium containing 5% fetal bovine serum were inoculated into 96-well 96- 5000 cells / well, and cultured at 37 ° C and 10% CO 2 for 24 hours. After 24 hours, the samples were diluted with IMDM medium containing no fetal bovine serum for 2 days, and cell culture medium was collected. The amount of pro-collagen type IC-peptide (Type IC-peptide: PICP) synthesized by using the collagen protein assay system (Procollagen Type IC-peptide EIA Kit (MK101) Respectively.

측정방법은 우선 콜라겐 항체가 균일하게 도포되어 있는 96공 평판배양기에 POD(perosidase) 효소가 결합된 항체용액 100㎕와 채취된 세포배양액 20㎕를 넣고 37℃에서 3시간 동안 반응시켰다. 3시간 후 상등액을 모두 제거하고 각 well을 400㎕의 PBS(phosphate buffered saline)로 4회 세척하였다. 세척 후 각 well에 POD와 반응하는 기질용액 100㎕를 넣고 상온에서 15분간 방치하였다. 반응을 정지시키기 위해 1N 황산용액 100㎕를 첨가하여 혼합한 다음 450nm에서 흡광도를 측정하였다. PICP양은 콜라겐 측정 키트에 포함되어 있는 표준용액을 희석하여 작성된 표준농도곡선에 샘플의 흡광도를 대입하여 계산하였다. 또한 시료를 처리하지 않은 세포 배양액의 반응 흡광도를 대조군으로 하였다.For the measurement, 100 μl of the antibody solution in which the POD (perosidase) enzyme was bound and 20 μl of the collected cell culture were added to a 96-well plate incubator uniformly coated with the collagen antibody, and reacted at 37 ° C. for 3 hours. After 3 hours, the supernatant was removed and each well was washed 4 times with 400 μl of PBS (phosphate buffered saline). After washing, 100 μl of substrate solution reacting with POD was added to each well and left at room temperature for 15 minutes. To stop the reaction, 100 1 of 1 N sulfuric acid solution was added and mixed, and the absorbance at 450 nm was measured. The PICP amount was calculated by substituting the absorbance of the sample into the standard concentration curve prepared by diluting the standard solution contained in the collagen measurement kit. The reaction absorbance of the cell culture without sample treatment was used as a control.

콜라겐 합성 촉진 효과  Promoting collagen synthesis
시료

sample
콜라겐 합성율(%, control)Collagen synthesis rate (%, control)
처리농도(㎍/㎖)Treatment concentration ([mu] g / ml) 0.50.5 1One 22 가막살나무 잎, 가지 혼합 추출물Extract of gabbro leaves, eggplant mixture 356.31356.31 358.53358.53 313.27313.27 VD-LBE
헥산 분획물
VD-LBE
Hexane fraction
123.02123.02 169.65169.65 226.00226.00
VD-LBE
클로로포름 분획물
VD-LBE
Chloroform fraction
251.54251.54 278.83278.83 233.94233.94
VD-LBE
에틸아세테이트 분획물
VD-LBE
Ethyl acetate fraction
330.73330.73 340.18340.18 349.40349.40
VD-LBE
부탄올 분획물
VD-LBE
Butanol fraction
153.74153.74 203.77203.77 287.63287.63
대조군Control group 100100

표 4에 나타난 바와 같이 VD-LBE과 정제된 분획물 모두 시료를 처리하지 않은 대조군보다 2배 이상의 콜라겐 합성을 증가시켰음을 확인하였다.As shown in Table 4, both VD-LBE and purified fractions increased collagen synthesis more than twice as much as the control group not treated with the sample.

이상의 결과들에서 부탄올 분획물은 항산화 효과와 주름개선 효과에서 공통적으로 유효성을 갖는 것으로 조사 되었다.From the above results, it was found that the butanol fraction had common efficacy in antioxidative and wrinkle - reducing effects.

실험예 5: SLS(Sodiul lauryl sulfate)에 의해 유발되는 세포독성 완화 효과Experimental Example 5: Cytotoxic relaxation effect induced by SLS (Sodium lauryl sulfate)

SLS(Sodiul lauryl sulfate)는 화장품에 첨가되는 계면활성제로 접촉성 피부염을 일으키는 대표적인 부식성 자극물질로 피부장벽 기능의 손실을 유발하며 경표피 수분손실을 증가시킨다. 본 실험예에서는 수득한 시료들의 인간 정상 섬유아세포에 대한 SLS 자극완화 효과를 평가하고자 세포 배양 기술을 이용하여 실험을 수행하였다.SLS (Sodiulylauryl sulfate) is a surfactant added to cosmetics. It is a typical corrosive irritant causing contact dermatitis. It causes loss of skin barrier function and increases water loss. In this Experimental Example, experiments were carried out using cell culture technology to evaluate the SLS stimulation relaxation effect on the human normal fibroblasts of the obtained samples.

사람의 정상 섬유아세포(Human normal fibroblast)를 IMDM 배지가 들어 있는 96-웰 마이크로 플레이트에 접종시키고 (2×104 세포/well), 10% CO2 조건에서 37℃로 24시간 배양하였다. 상기 사람의 정상 섬유아세포는 ATCC(Americal Type Culture Collection)에서 구입하였다. 먼저 예비 실험을 통해 VD-LBE의 추출물이 10㎍/㎖ 농도 이내에서 세포 독성이 없음을 동일조건의 실험을 통해 확인하였다. 그 후 100㎍/㎖ SLS와 농도별로 희석된 각 추출물시료를 동시에 처리하고, 또한 동일조건하에서 추출물시료만 없는 경우를 대조군으로 하여 비교 실험하였다. 48시간 배양 후 배지를 제거하고 각 웰당 200㎕의 디메틸설폭시드(DMSO : Dimethyl sulfoxide) 용액을 가해 20분간 교반하여 생성된 formazan을 녹였다. 마이크로플레이트 리더(microplate reader)를 이용, 540nm에서 흡광도를 측정하여 대조군과의 비교를 통해 시료의 SLS에 의한 세포 독성 완화 효과를 확인하였다.Human normal fibroblasts were inoculated (2 x 10 4 cells / well) into 96-well microplates containing IMDM medium and cultured at 37 ° C for 24 hours at 10% CO 2 . The normal human fibroblasts were purchased from the American Type Culture Collection (ATCC). First, preliminary experiments confirmed that the extract of VD-LBE was not cytotoxic within 10 μg / ml concentration. Thereafter, 100 μg / ml SLS and diluted extract extracts were simultaneously treated and, in the case of no extract, only control samples were used as a control. After 48 hours of culture, the medium was removed, and 200 μl of dimethyl sulfoxide (DMSO) solution was added to each well. The resulting solution was stirred for 20 minutes to dissolve the generated formazan. Absorbance was measured at 540 nm using a microplate reader, and the cytotoxic relaxation effect of SLS by the sample was confirmed through comparison with the control group.

SLS에 의해 유도된 세포독성 완화 효과  SLS-induced cytotoxicity mitigation effect 시료sample 세포생존율(%)Cell survival rate (%) 0.1㎍/㎖0.1 mu g / ml 1㎍/㎖1 mu g / ml 5㎍/㎖5 / / ml 10㎍/㎖10 mu g / ml 가막살나무 잎, 가지 혼합 추출물Extract of gabbro leaves, eggplant mixture 117.26117.26 119.54119.54 120.57120.57 117.79117.79 대조군Control group 100100

표 5의 결과로부터 VD-LBE에서 세포독성 완화 효과가 5㎍/㎖에서 가장 우수함을 알 수 있었으며, 본 발명의 가막살나무 잎, 가지 혼합 추출물은 화장료 조성물에 포함되었을 때 계면활성제에 의해 나타날 수 있는 피부 자극을 완화할 수 있는 물질임을 확인하였다.From the results shown in Table 5, it was found that the cytotoxic relaxation effect of VD-LBE was the best at 5 μg / ml, and that the mixed extract of V. falcatum and leaves of the present invention can be exhibited by a surfactant It was confirmed that it is a substance that can alleviate skin irritation.

Claims (8)

가막살나무 잎, 가지 혼합 추출물을 포함하는 피부주름개선용 화장료 조성물.A cosmetic composition for improving skin wrinkles, comprising a mixture of the leaves of Vincennesiaceae and the mixture of plant extracts. 가막살나무 잎, 가지 혼합 추출물에 헥산, 메틸렌클로라이드, 에틸아세테이트, 부탄올을 순차적으로 가한 후 분획하여 얻은 1종 이상의 용매분획물을 포함하는 피부주름개선용 화장료 조성물.Wherein at least one solvent fraction obtained by sequentially adding hexane, methylene chloride, ethyl acetate, and butanol to a mixture of the leaves of cinnamomum oil and the mixture of branches is fractionated and fractionated. 제2항에 있어서, 용매분획물이 부탄올분획물 임을 특징으로 하는 피부주름개선용 화장료 조성물.The cosmetic composition for improving skin wrinkles according to claim 2, wherein the solvent fraction is butanol fraction. 제1항에 있어서, 가막살나무 잎, 가지 혼합 추출물은 에탄올 추출물이며, 그 함량은 조성물 전체중량의 0.005 내지 1 중량% 임을 특징으로 하는 피부주름개선용 화장료 조성물.[Claim 2] The cosmetic composition for improving skin wrinkles according to claim 1, wherein the extract of V. fructus is ethanol extract and the content thereof is 0.005 to 1% by weight of the total weight of the composition. 제1항 또는 제2항에 있어서, 피부주름개선효과가 elastase의 활성저해효과에 기인한 것임을 특징으로 하는 피부주름개선용 화장료 조성물.The cosmetic composition for improving skin wrinkles according to claim 1 or 2, wherein the wrinkle-reducing effect of the skin is caused by an activity inhibiting effect of elastase. 제1항 또는 제2항에 있어서, 피부주름개선효과가 MMP-1의 활성저해효과에 기 인한 것임을 특징으로 하는 피부주름개선용 화장료 조성물.The cosmetic composition for improving skin wrinkles according to claim 1 or 2, wherein the wrinkle improving effect is due to the inhibitory effect of MMP-1. 제1항 또는 제2항에 있어서, 피부주름개선효과가 콜라겐 합성 촉진 효과에 기인한 것임을 특징으로 하는 피부주름개선용 화장료 조성물.The cosmetic composition for improving skin wrinkles according to any one of claims 1 to 3, wherein the effect of improving skin wrinkles is due to the effect of promoting collagen synthesis. 제1항 또는 제2항에 있어서, 피부세포독성 완화 효과가 있는 피부주름 개선용 화장료 조성물.The cosmetic composition for improving skin wrinkles according to claim 1 or 2, which has a skin cell toxicity-reducing effect.
KR1020080022256A 2008-03-11 2008-03-11 cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle KR101398392B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080022256A KR101398392B1 (en) 2008-03-11 2008-03-11 cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080022256A KR101398392B1 (en) 2008-03-11 2008-03-11 cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle

Publications (2)

Publication Number Publication Date
KR20090097232A KR20090097232A (en) 2009-09-16
KR101398392B1 true KR101398392B1 (en) 2014-05-28

Family

ID=41356611

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080022256A KR101398392B1 (en) 2008-03-11 2008-03-11 cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle

Country Status (1)

Country Link
KR (1) KR101398392B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102214505B1 (en) * 2020-09-08 2021-02-10 주식회사 사임당화장품 Skin External Preparation and Cosmetic Compositions Comprising Extract of Viburnum erosum Thunb.
KR20210055622A (en) 2019-11-06 2021-05-17 한국생명공학연구원 Cosmetic Composition for Preventing Skin Aging and Improving Skin Winkle comprising Extract of Viburnum stellato-tomentosum

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101126984B1 (en) 2011-12-14 2012-03-21 제니코스(주) Cosmetic composition comprising extract of taxodium distichum and viburnum sargentii for sterile for whitening and antioxdiant
KR101323068B1 (en) 2011-09-29 2013-10-29 주식회사 코리아나화장품 Cosmetic composition comprising the extract of Viburnum odoratissimum var. awabuki as active ingredient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323068B1 (en) 2011-09-29 2013-10-29 주식회사 코리아나화장품 Cosmetic composition comprising the extract of Viburnum odoratissimum var. awabuki as active ingredient
KR101126984B1 (en) 2011-12-14 2012-03-21 제니코스(주) Cosmetic composition comprising extract of taxodium distichum and viburnum sargentii for sterile for whitening and antioxdiant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Appl. Biol. Chem. 50(4), 215-220 (2007) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210055622A (en) 2019-11-06 2021-05-17 한국생명공학연구원 Cosmetic Composition for Preventing Skin Aging and Improving Skin Winkle comprising Extract of Viburnum stellato-tomentosum
KR102508159B1 (en) * 2019-11-06 2023-03-10 한국생명공학연구원 Cosmetic Composition for Preventing Skin Aging and Improving Skin Winkle comprising Extract of Viburnum stellato-tomentosum
KR102214505B1 (en) * 2020-09-08 2021-02-10 주식회사 사임당화장품 Skin External Preparation and Cosmetic Compositions Comprising Extract of Viburnum erosum Thunb.

Also Published As

Publication number Publication date
KR20090097232A (en) 2009-09-16

Similar Documents

Publication Publication Date Title
US11752168B2 (en) Methods of using cosmetic compositions comprising exopolysaccharides derived from microbial mats
JP2020514279A (en) Composition comprising an extract of a Hedychium coronarium species plant for use in a method of therapeutically treating the human body
KR20070002409A (en) Cosmetic composition containing as available ingredient the extracts of Equisetum arvense L.
KR101853743B1 (en) External composition for skin containing Kalopanax pictus (Thunb.) Nakai extract
KR101558182B1 (en) Skin External Composition Containing Extracts of Chrysanthemum indicum var. albescens
KR101398392B1 (en) cosmetic compositions containing extract of Viburnum dilatatum Thunb used for antiwrinkle
KR20090029873A (en) Cosmetic compositions used for antiaging and antiwrinkle
KR20080061080A (en) Cosmetic composition comprising tuber melanosporum
KR100898307B1 (en) Cosmetic composition with the antioxidant effect protecting skins aging
JP3496967B2 (en) Antiplasmin agent
KR100866784B1 (en) Cosmetic compositions containing extract of carpinus tschonoskii used for antiwrinkle
KR100604244B1 (en) Cosmetic composition containing Solanum Lycopersicum MILL.Extract
KR102337308B1 (en) Composition for preventing or improving skin aging containing (-)-eudesmin
KR100967805B1 (en) cosmetic compositions containing extract of Ostrya japonica Sarg used for antiwrinkle
KR101008833B1 (en) cosmetic compositions containing extract of Sorbus alnifolia S. et Z. K. Koch used for antiwrinkle
KR101441190B1 (en) Cosmetic composition containing Oreocnide fruticosa extraction
KR20110063912A (en) A topical composition comprising the extract of platycodi radix, bupleuri radix and ginseng radix and the purified fractions therefrom inhibiting skin aging and wrinkle formation
KR101155512B1 (en) A skin protective composition from Ecklonia stolonifera
KR20010018668A (en) A cosmetic composition containing Cinnamomi Cortex extracts
KR102052522B1 (en) Anti-oxidating composition containing Panax ginseng polysaccharides and Green tea polysaccharides
CN113384510B (en) Fermented composition with anti-photoaging, relieving and cooling effects and preparation method and application thereof
KR102597794B1 (en) Composition for improving skin condition comprising epidermal growth factor and extract of aronia melanocarpa fruit
KR20090089982A (en) Cosmetic compositions containing extract of empetrum nigrum var. japonicum used for antiwrinkle
ES2420514B1 (en) Erica erigena formulations and extracts to fight skin aging
KR20130113474A (en) Polyphenolic grape extract and cosmetic product comprising said extract

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
N231 Notification of change of applicant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170502

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180105

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20181212

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20191212

Year of fee payment: 7